BACH2
Basic information
Region (hg38): 6:89926528-90296843
Links
Phenotypes
GenCC
Source:
- immunodeficiency 60 (Limited), mode of inheritance: AD
- immunodeficiency 60 (Strong), mode of inheritance: AD
- immunodeficiency 60 (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 60 and autoimmunity | AD | Allergy/Immunology/Infectious | Individuals may manifest with findings such as inflammatory bowel disease and recurrent sinopulmonary infections and antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial | Allergy/Immunology/Infectious | 28530713 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BACH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 139 | 12 | 152 | |||
missense | 226 | 14 | 242 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 3 | 5 | |||
non coding | 12 | |||||
Total | 0 | 0 | 232 | 161 | 18 |
Variants in BACH2
This is a list of pathogenic ClinVar variants found in the BACH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-89932398-A-T | BACH2-related disorder | Benign (Feb 21, 2019) | ||
6-89932401-C-T | BACH2-related disorder | Likely benign (Sep 18, 2019) | ||
6-89932412-G-C | Uncertain significance (Feb 09, 2023) | |||
6-89932414-A-G | Likely benign (Mar 15, 2022) | |||
6-89932423-C-T | Likely benign (Mar 01, 2023) | |||
6-89932429-C-T | not specified | Likely benign (Dec 18, 2023) | ||
6-89932435-G-A | Likely benign (Jan 08, 2024) | |||
6-89932453-A-T | Likely benign (Jan 11, 2022) | |||
6-89932465-G-A | Likely benign (May 25, 2022) | |||
6-89932476-C-G | not specified | Uncertain significance (Mar 23, 2022) | ||
6-89932476-C-T | Likely benign (Jan 14, 2023) | |||
6-89932477-G-A | Likely benign (Jan 25, 2024) | |||
6-89932489-G-A | Likely benign (Jan 07, 2024) | |||
6-89932506-G-A | Uncertain significance (Sep 23, 2021) | |||
6-89932510-T-C | Likely benign (Oct 27, 2023) | |||
6-89932516-C-G | Immunodeficiency 60 | Likely benign (Dec 31, 2023) | ||
6-89932518-C-G | Immunodeficiency 60 | Uncertain significance (Feb 14, 2023) | ||
6-89932523-A-G | Uncertain significance (Jan 10, 2024) | |||
6-89932531-C-T | Likely benign (Sep 08, 2023) | |||
6-89932532-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
6-89932542-C-A | Uncertain significance (Jan 04, 2024) | |||
6-89932548-G-C | Uncertain significance (Apr 06, 2023) | |||
6-89932549-T-C | Likely benign (May 11, 2023) | |||
6-89932568-T-G | not specified | Uncertain significance (Nov 17, 2023) | ||
6-89932572-C-T | Immunodeficiency 60 | Uncertain significance (Dec 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BACH2 | protein_coding | protein_coding | ENST00000257749 | 4 | 370380 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00197 | 125739 | 0 | 4 | 125743 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.30 | 361 | 506 | 0.713 | 0.0000313 | 5523 |
Missense in Polyphen | 83 | 165.59 | 0.50125 | 1858 | ||
Synonymous | 0.00675 | 219 | 219 | 0.999 | 0.0000151 | 1673 |
Loss of Function | 4.46 | 2 | 27.0 | 0.0740 | 0.00000133 | 343 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional regulator that acts as repressor or activator (By similarity). Binds to Maf recognition elements (MARE) (By similarity). Plays an important role in coordinating transcription activation and repression by MAFK (By similarity). Induces apoptosis in response to oxidative stress through repression of the antiapoptotic factor HMOX1 (PubMed:17018862). Positively regulates the nuclear import of actin (By similarity). {ECO:0000250|UniProtKB:P97303, ECO:0000269|PubMed:17018862}.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- loftool
- 0.0845
- rvis_EVS
- -0.62
- rvis_percentile_EVS
- 17.45
Haploinsufficiency Scores
- pHI
- 0.966
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.761
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bach2
- Phenotype
- hematopoietic system phenotype; immune system phenotype; skeleton phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;import into nucleus
- Cellular component
- nucleus;cytosol
- Molecular function
- RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity